Related Experiment Video
Updated: Sep 14, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Developing an interpretable machine learning predictive model of chronic obstructive pulmonary disease by serum PFAS
Xiaomei Shao1, Ling Zhang2, Yuting Wang1
1Nanjing Jiangbei Hospital, Affiliated Nanjing Jiangbei Hospital of Xinglin College, Nantong University, Jiangsu, China.
Certain per- and polyfluoroalkyl substances (PFAS) like PFOS and PFUA may protect against chronic obstructive pulmonary disease (COPD), while others like PFOA increase risk. Machine learning models can predict COPD risk based on PFAS exposure.
Area of Science:
- Environmental Health
- Toxicology
- Data Science
Background:
- Chronic obstructive pulmonary disease (COPD) poses a significant global health burden with limited early detection methods.
- Research on the link between per- and polyfluoroalkyl substances (PFAS) and COPD exists, but few studies utilize interpretable machine learning (ML).
Purpose of the Study:
- To investigate the association between exposure to various PFAS and the risk of developing COPD.
- To develop and validate an interpretable ML model for predicting COPD risk based on PFAS exposure levels.
Main Methods:
- Utilized data from 4,450 National Health and Nutrition Examination Survey (NHANES) participants (2013-2018).
- Applied data cleaning, K-nearest neighbors (KNN) imputation, and developed nine ML models, including CatBoost.
- Evaluated models using accuracy, AUC, sensitivity, and specificity; further analyzed the best model with PDP and SHAP.
- Deployed the final model as a public web-based risk calculator.
Main Results:
- The CatBoost model achieved 84% accuracy, 0.89 AUC, 81% sensitivity, and 84% specificity.
- Higher levels of perfluorooctane sulfonic acid (PFOS) and perfluoroundecanoic acid (PFUA) were linked to decreased COPD risk.
- Perfluorooctanoic acid (PFOA) and 2-(N-Methyl-perfluorooctane sulfonamido) acetic acid (MPAH) showed positive associations with increased COPD risk.
- Other PFAS like PFNA, PFDE, and PFHxS exhibited mixed or non-linear effects.
Conclusions:
- PFOS and PFUA act as protective factors against COPD, whereas PFOA and MPAH elevate COPD risk.
- Interpretable ML, particularly CatBoost, effectively clarifies complex PFAS-COPD relationships.
- Findings support the need for stricter PFAS regulations and underscore ML's role in public health prevention strategies.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

